U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(8)
(3)
(17)
(11)
(16)
(13)
(27)
(33)
(21)
(46)
(33)
(34)
(33)
(23)
(25)
(18)
(19)
(27)
(21)
(29)
(13)
(15)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(121)
(20)
(1)
(643)
0 of 4
(7)
(1)
(3)
(8)
(7)
(31)
(1)
(10)
(7)
(3)
(13)
(1)
(1)
(1)
(1)
(105)
(1)
(1)
(7)
(3)
(2)
(1)
(1)
(6)
(49)
(2)
(121)
(14)
(55)
(2)
(30)
(6)
(4)
(1)
(7)
(1)
(2)
(405)
(2)
(6)
(13)
(2)
(1)
0 of 43
(7)
(2)
(40)
(1)
(3)
(2)
(2)
(7)
0 of 8
(53)
(6)
(5)
(1)
(3)
(12)
(564)
(1)
(1)
(28)
(41)
(63)
0 of 12
(455)
(30)
(271)
(1)
0 of 4
(130)
(19)
0 of 2
(138)
(9)
(1)
0 of 3
(2)
(1)
(9)
(8)
(6)
(2)
(1)
(1)
(1)
(1)
(16)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(4)
(35)
(2)
(9)
(5)
(2)
(1)
(8)
(3)
(3)
(7)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(30)
(1)
(8)
(21)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(36)
(6)
(1)
(6)
(3)
(13)
(2)
(2)
(1)
(5)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(8)
(1)
(3)
(3)
(1)
(7)
(6)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(1)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(4)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(6)
(2)
(4)
(5)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(4)
(6)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(22)
(2)
(13)
(3)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(6)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(92)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(2)
(3)
(3)
(3)
(2)
(2)
(7)
(2)
(3)
(9)
(2)
(5)
(2)
(3)
(4)
(14)
(3)
(2)
(10)
(4)
(3)
(7)
(3)
(4)
(6)
(2)
(2)
(2)
(2)
(12)
(2)
(2)
(10)
(3)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(11)
(10)
(2)
(15)
(9)
(3)
(2)
(3)
(2)
(5)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(3)
(3)
(2)
(8)
(5)
(2)
(2)
(2)
(2)
(2)
(3)
(10)
(10)
(2)
(2)
(2)
(3)
(2)
(21)
(4)
(2)
(6)
(30)
(25)
(13)
(2)
(5)
(2)
(8)
(2)
(3)
(2)
(5)
(8)
(2)
(2)
(3)
(7)
(2)
(2)
(5)
(3)
(2)
(9)
(11)
(2)
(3)
(2)
(2)
(4)
(7)
(6)
(6)
(2)
(2)
(2)
(4)
(3)
(2)
(25)
(15)
(2)
(3)
(5)
(32)
(2)
(2)
(5)
(2)
(3)
(15)
(2)
(2)
(4)
(5)
(4)
(7)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(5)
(3)
(4)
(2)
(4)
(64)
(2)
(3)
(3)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(2)
(5)
(3)
(2)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(2)
(2)
(4)
(13)
(8)
(3)
(78)
(3)
(12)
(7)
(3)
(5)
(3)
(21)
(2)
(3)
(5)
(13)
(4)
(2)
(2)
(2)
(3)
(3)
(2)
(5)
(5)
(4)
(2)
(5)
(3)
(3)
(3)
(2)
(4)
(2)
(8)
(4)
(2)
(2)
(8)
(4)
(5)
(2)
(2)
(2)
(2)
(10)
(7)
(6)
(2)
(3)
(3)
(43)
(2)
(5)
(4)
(2)
(4)
(2)
(2)
(2)
(13)
(9)
(6)
(4)
(6)
(6)
(6)
(2)
(2)
(2)
(3)
(2)
(221)
(12)
(2)
(2)
(2)
(2)
(10)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(2)
(10)
(2)
(2)
(4)
(2)
(3)
(5)
(83)
(30)
(32)
(9)
(10)
(2)
(7)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(5)
(3)
(3)
(5)
(2)
(2)
(10)
(2)
(5)
(12)
(2)
(5)
(2)
(2)
(3)
(2)
(14)
(3)
(3)
(2)
(2)
(3)
(4)
(5)
(2)
(3)
(2)
(2)
(2)
(13)
(3)
(4)
(4)
(11)
(11)
(2)
(42)
(3)
(29)
(2)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(11)
(7)
(2)
(2)
(2)
(3)
(43)
(2)
(6)
(4)
(2)
(4)
(8)
(8)
(8)
(5)
(2)
(9)
(6)
(7)
(2)
(2)
(4)
(3)
(6)
(2)
(2)
(27)
(2)
(140)
(167)
(2)
(4)
(3)
(2)
(2)
(2)
(5)
(6)
(7)
(4)
(4)
(10)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(36)
(5)
(4)
(2)
(2)
(4)
(2)
(4)
(4)
(10)
(3)
(2)
(4)
(2)
(11)
(2)
(2)
(5)
(2)
(3)
(5)
(23)
(3)
(6)
(2)
(2)
(3)
(2)
(22)
(6)
(3)
(60)
(3)
(23)
(2)
(4)
(4)
(2)
(2)
(2)
(2)
(6)
(2)
(2)
(17)
(2)
(2)
(2)
(6)
(2)
(13)
(2)
(16)
(5)
(5)
(4)
(4)
(3)
(24)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(3)
(10)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(10)
(2)
(18)
(22)
(5)
(3)
(2)
(7)
(12)
(31)
(41)
(3)
(4)
(2)
(2)
(2)
(3)
(2)
(3)
(5)
(166)
(24)
(7)
(2)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(7)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(4)
(2)
(4)
(4)
(2)
(2)
(7)
(2)
(2)
(13)
(5)
(6)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(19)
(15)
(7)
(3)
(5)
(5)
(2)
(3)
(2)
(3)
(3)
(3)
(2)
(4)
(3)
(2)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(3)
(2)
(2)
(6)
(2)
(2)
(2)
(37)
(2)
(2)
(14)
(2)
(2)
(2)
(8)
(19)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(6)
(10)
(87)
(2)
(23)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(5)
(14)
(3)
(2)
(2)
(7)
(3)
(2)
(5)
(4)
(8)
(6)
(3)
(4)
(2)
(2)
(10)
(3)
(2)
(3)
(9)
(2)
(12)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(5)
(3)
0 of 1000
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(13)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(1)
(4)
(1)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(10)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(6)
(2)
(2)
(2)
(7)
(2)
(5)
(3)
(4)
(3)
(2)
(7)
(2)
(2)
(5)
(2)
(2)
(5)
(6)
(2)
(2)
(3)
(3)
(4)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(5)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(3)
0 of 1000
(1)
(6)
(1)
(3)
(19)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(26)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(270)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(2)
(3)
(2)
(5)
(2)
(3)
(1)
(19)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(4)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(1)
(4)
(4)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(7)
(6)
(4)
(9)
(17)
(2)
(1)
(1)
(1)
(4)
(6)
(1)
(4)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(8)
(3)
(7)
(1)
(1)
(142)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(122)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
0 of 436
(1)
(1)
(8)
(4)
(1)
(1)
(8)
(88)
(1)
(2)
(50)
(231)
(1)
(25)
(1)
(78)
(1)
(28)
(2)
(7)
(145)
(1)
(4)
(1)
(4)
0 of 25
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(6)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 227
Showing 401 - 420 of 786 results
  • Final recommendations for protecting human health from potential adverse effects of exposure to agents GA Tabun GB Sarin and VX
    Final recommendations for protecting human health from potential adverse effects of exposure to agents GA (Tabun), GB (Sarin), and VX
    National Center for Environmental Health (U.S.). Division of Emergency and Environmental Health Services.
    October 9, 2003 | Federal register ; v. 68, no. 196, p. 58348-58351
    SUMMARY: Agents GA, GB, and VX are
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports October 3 2003 Vol 52 No RR14
    Morbidity and Mortality Weekly Report: Recommendations and Reports, October 3, 2003 / Vol. 52 / No. RR-14
    Bilukha, Oleg O. ;
    Briss, Peter
    October 3, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    First reports evaluating the effectiveness of strategies for preventing violence : early childhood home visitation. Early childhood home visitation programs are those in which parents and children are visited in their home during the child's first 2 years of life by trained personnel who provide some combination of the following: information, suppo ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports September 26 2003 Vol 52 No RR13
    Morbidity and Mortality Weekly Report: Recommendations and Reports, September 26, 2003 / Vol. 52 / No. RR-13
    Bridges, Carolyn B. ;
    Cox, Nancy (Nancy J.)
    September 26, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the United States on June 17, 2003 (FluMist trade mark, produced by MedImmune, Inc., Gaithersburg, Maryland). LAIV is ...
    Superseded Public Domain
  • Update Adverse Event Data and Revised American Thoracic SocietyCDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis InfectionUnited States 2003
    Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003
    Centers for Disease Control and Prevention (U.S.)  ...
    August 8, 2003 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    A previously published report provided guidelines for managing the pharmacologic interactions that can result when patients receive protease inhibitors and nonnucleoside reverse transcriptase inhibitors (NNRTIs) for treatment of human immunodeficiency virus (HIV) infection together with rifamycins for the treatment of tuberculosis (TB). Protease in ...
    Current Public Domain
  • Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients Updated Recommendations of the Advisory Committee on Immunization Practices
    Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients: Updated Recommendations of the Advisory Committee on Immunization Practices
    United States. Advisory Committee on Immunization Practices.  ...
    August 8, 2003 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In October 2002, CDC recommended that all persons with cochlear implants receive age-appropriate pneumococcal vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) (Prevnar), 23-valent pneumococcal polysaccharide vaccine (PPV23) (Pneumovax), or both according to the Advisory Committee on Immunization Practices (ACIP) schedules for persons ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports July 18 2003 Vol 52 No RR12
    Morbidity and Mortality Weekly Report: Recommendations and Reports, July 18, 2003 / Vol. 52 / No. RR-12
    Centers for Disease Control and Prevention (U.S.)  ...
    July 18, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Reducing transmission of human immunodeficiency virus (HIV) in the United States requires new strategies, including emphasis-sis on prevention of transmission by HIV-infected persons. Through ongoing attention to prevention, risky sexual and needle-sharing behaviors among persons with HIV infection can be reduced and transmission of HIV infection p ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports February 21 2003 Vol 52 No RR4
    Morbidity and Mortality Weekly Report: Recommendations and Reports, February 21, 2003 / Vol. 52 / No. RR-4
    Cono, Joanne, 1962- ;
    Casey, Christine G.
    February 21, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "The guidance in this report is for evaluation and treatment of patients with complications from smallpox vaccination in the preoutbreak setting. Information is also included related to reporting adverse events and seeking specialized consultation and therapies for these events. The frequencies of smallpox vaccine-associated adverse events were ide ...
    Current Public Domain
  • Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus
    Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus
    Alter, Miriam J. ;
    Kuhnert, Wendi L.
    February 7, 2003 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-3
    Testing for the presence of antibody to hepatitis C virus (anti-HCV) is recommended for initially identifying persons with hepatitis C virus (HCV) infection (CDC. Recommendations for prevention and control of hepatitis C virus [HCV] infection and HCV-related chronic disease. MMWR 1998;47[No. RR-19] :1-33). Testing for anti-HCV should include use of ...
    Superseded Public Domain
  • Notice to Readers Supplemental Recommendations on Adverse Events Following Smallpox Vaccine in the PreEvent Vaccination Program Recommendations of the Advisory Committee on Immunization Practices
    Notice to Readers: Supplemental Recommendations on Adverse Events Following Smallpox Vaccine in the Pre-Event Vaccination Program: Recommendations of the Advisory Committee on Immunization Practices
    United States. Advisory Committee on Immunization Practices.
    April 4, 2003 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Advisory Committee on Immunization Practices (ACIP) has issued recommendations previously for use of smallpox vaccine (1) and supplemental recommendations for use of smallpox vaccine in the pre-event civilian vaccination program (2). On March 28, 2003, CDC reported cases of cardiac adverse events among persons vaccinated recently with smallpox ...
    Current Public Domain
  • Guidance for Filtration and AirCleaning Systems to Protect Building Environments from Airborne Chemical Biological or Radiological Attacks
    Guidance for Filtration and Air-Cleaning Systems to Protect Building Environments from Airborne Chemical, Biological, or Radiological Attacks
    National Institute for Occupational Safety and Health
    2003/04/01 | NIOSH Numbered Publications
    This document discusses air-filtration and air-cleaning issues associated with protecting building environments from an airborne chemical, biological, or radiological (CBR) attack. It provides information about issues that should be considered when assessing, installing, and upgrading filtration systems-along with the types of threats that can be a ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports March 28 2003 Vol 52 No RR6
    Morbidity and Mortality Weekly Report: Recommendations and Reports, March 28, 2003 / Vol. 52 / No. RR-6
    Redd, Stephen C. ;
    Schmidt, Diana K.
    March 28, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    In 1997, the National Asthma Education and Prevention Program (NAEPP), coordinated by the National Heart, Lung, and Blood Institute, published the second Expert Panel Report (EPR-2): Guidelines for the Diagnosis and Management of Asthma (National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports March 21 2003 Vol 52 No RR5
    Morbidity and Mortality Weekly Report: Recommendations and Reports, March 21, 2003 / Vol. 52 / No. RR-5
    National Association of State Public Health Veterinarians, Inc. (NASPHV)
    March 21, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Rabies is a fatal viral zoonosis and a serious public health problem. The purpose of this compendium is to provide information to veterinarians, public health officials, and others concerned with rabies prevention and control. These recommendations serve as the basis for animal rabies-control programs throughout the United States and facilitate sta ...
    Superseded Public Domain
  • Guidelines for Case Classification for the National Birth Defects Prevention Study
    Guidelines for Case Classification for the National Birth Defects Prevention Study
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
    March 2003 | Birth defects research. Part A, Clinical and molecular teratology. 2003; 67(3):193-201.
    BACKGROUND: Previous studies have suggested that etiologic heterogeneity may complicate epidemiologic analyses designed to identify risk factors for birth defects. Case classification uses knowledge of embryologic and pathogenetic mechanisms to make case groups more homogeneous and is important to the success of birth defects studies. METHODS: The ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report MMWR Dispatch January 31 2003 Vol 52 No 4
    Morbidity and Mortality Weekly Report (MMWR): Dispatch, January 31, 2003 / Vol. 52 / No. 4
    United States. Advisory Committee on Immunization Practices  ...
    January 31, 2003 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Each year, CDC's Advisory Committee on Immunization Practices (ACIP) reviews the recommended childhood and adolescent immunization schedule to ensure that it is current with changes in manufacturers' vaccine formulations and contains revised recommendations for the use of licensed vaccines, including those newly licensed. The recommended childhood ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports January 31 2003 Vol 52 No RR2
    Morbidity and Mortality Weekly Report: Recommendations and Reports, January 31, 2003 / Vol. 52 / No. RR-2
    Mandy, Francis F. ;
    Mazurek, Gerald H.
    January 31, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Summary of "Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus": These guidelines were developed by CDC for laboratorians who perform immunophenotyping for detection and enumeration of CD4+ T-cells and other lymphocyte subsets in persons infected with ...
    Public Domain
  • Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
    Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
    January 28, 2003 | Circulation. 2003; 107(3):499-511.
    No Description
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports January 24 2003 Vol 52 No RR1
    Morbidity and Mortality Weekly Report: Recommendations and Reports, January 24, 2003 / Vol. 52 / No. RR-1
    Lyerla, Harold Craig ;
    Margolis, Harold S.
    January 24, 2003 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report consolidates previous recommendations and adds new ones for preventing and controlling infections with hepatitis viruses in correctional settings. These recommendations provide guidelines for juvenile and adult correctional systems regarding 1) identification and investigation of acute viral hepatitis; 2) preexposure and postexposure im ...
    Current Public Domain
  • Epidemicepizootic West Nile virus in the United States guidelines for surveillance prevention and control 3rd revision
    Epidemic/epizootic West Nile virus in the United States : guidelines for surveillance, prevention, and control. 3rd revision
    Gubler, Duane J. ;
    Petersen, Lyle R.
    2003
    In late summer 1999, the first domestically acquired human cases of West Nile (WN) encephalitis were documented in the U.S. The discovery of virus-infected, overwintering mosquitoes during the winter of 1999-2000 presaged renewed virus activity for the following spring and precipitated early season vector control and disease surveillance in New Yor ...
    Superseded Public Domain
  • Surviving a Public Health Crisis Tips for Communicators
    Surviving a Public Health Crisis: Tips for Communicators
    Golan, Kay
    2003 | Journal of health communication. 2003; 8 Suppl 1:126-7.
    A letter from Kay Golan, Director, Centers for Disease Control and Prevention Media Relations, 1998–2002, commending the Journal of Health Communication for their coverage of the anthrax attacks of 2001 and what health professionals learned from the experience.
    Retired Public Domain
  • Guidelines for Environmental Infection Control in HealthCare Facilities Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee HICPAC
    Guidelines for Environmental Infection Control in Health-Care Facilities; Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)
    Healthcare Infection Control Practices Advisory Committee (U.S.)  ...
    2003/01/01
    Infection-control strategies and engineering controls, when consistently implemented, are effective in preventing opportunistic, environmentally-related infections in immunocompromised populations. Adherence to proper use of disinfectants, proper maintenance of medical equipment that uses water (e.g., automated endoscope reprocessors and hydrothera ...
    Current Supporting Files Public Domain
401 - 420 / 786